These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16920421)

  • 21. Biologic predictors of survival in node-negative gastric cancer.
    Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
    Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serosal invasion as the single prognostic indicator in stage IIIA (T3N1M0) gastric cancer.
    Abe S; Shiraishi M; Nagaoka S; Yoshimura H; Dhar DK; Nakamura T
    Surgery; 1991 May; 109(5):582-8. PubMed ID: 2020903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
    Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and clinical evaluation of patients with T2 gastric cancer.
    Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
    Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
    Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS; Wu TL; Tsao KC; Sun CF
    Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival predictors in patients with node-negative gastric carcinoma.
    Lee CC; Wu CW; Lo SS; Chen JH; Li AF; Hsieh MC; Shen KH; Lui WY
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1014-8. PubMed ID: 17608847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multivariate prognostic analysis for patients with curative resection of gastric cardia cancer].
    Zhang CH; He YL; Zhan WH; Chen CQ; Cai SR; Huang MJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Nov; 9(6):483-7. PubMed ID: 17143790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significant prognostic factors in patients with node-negative gastric cancer.
    Yokota T; Kunii Y; Teshima S; Yamada Y; Saito T; Takahashi M; Kikuchi S; Yamauchi H
    Int Surg; 1999; 84(4):331-6. PubMed ID: 10667813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
    Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
    Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
    Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
    Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
    Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer.
    Shin SH; Jung H; Choi SH; An JY; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2009 May; 16(5):1304-9. PubMed ID: 19241107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic indicators in node-negative advanced gastric cancer patients.
    Saito H; Kuroda H; Matsunaga T; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2010 Jun; 101(7):622-5. PubMed ID: 20461771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer.
    Li C; Oh SJ; Kim S; Hyung WJ; Yan M; Zhu ZG; Noh SH
    Oncology; 2009; 77(3-4):197-204. PubMed ID: 19729977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced gastric carcinoma with signet ring cell histology.
    Li C; Kim S; Lai JF; Hyung WJ; Choi WH; Choi SH; Noh SH
    Oncology; 2007; 72(1-2):64-8. PubMed ID: 18004078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic strategy for patients with pN0 gastric carcinoma.
    Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
    J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection.
    Lai JF; Kim S; Li C; Oh SJ; Hyung WJ; Choi WH; Choi SH; Wang LB; Noh SH
    Ann Surg Oncol; 2008 May; 15(5):1464-9. PubMed ID: 18340495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic study of early-stage mucinous gastric carcinoma.
    Adachi Y; Yasuda K; Inomata M; Shiraishi N; Kitano S; Sugimachi K
    Cancer; 2001 Feb; 91(4):698-703. PubMed ID: 11241236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.